TOG Review (RCOG Journal)
MRCOG Part 2
Gynaecological Problems
A review of evidence-based management of uterine fibroids
Key Statistics
- ~30% — Lifetime prevalence of fibroids
- 1:4 — Women with fibroids who are symptomatic
- 36% — Leiomyoma size reduction, GnRH analogue (12WK)
Don't-miss facts
-
Only 1 in 4 women with fibroids are symptomatic; lifetime prevalence ~30%; median growth 9%/6 months supports expectant management if asymptomatic
-
GnRH analogue preoperative use capped at 6 months; ↓leiomyoma size by 36% at 12 weeks but blurs myomectomy dissection plane
-
PEARL I (UA): >90% ↓bleeding, fibroid volume change 41% vs 18%; PEARL II noninferior to leuprolide
-
UAE mortality 1:10,000 vs hysterectomy 3:10,000; but ~5-fold ↑reintervention risk vs surgery (23% at 5 years, HOPEFUL)
-
MRgFUS: NICE – research/audit use only; not for women wanting to preserve fertility; 21–28% need reintervention
-
ESGE/FIGO submucous fibroid grading (0/I/II): Grade 0/1 – easy hysteroscopic resection; Grade 2 (≥50% intramural) – depends on myometrium–serosa thickness
-
Resectoscopic slicing = gold standard for Grade 0 hysteroscopic myomectomy; no single proven technique for Grades 1–2
-
Fibroids cause one-third of US hysterectomies; laparoscopic myomectomy preferred if fertility desired
Evidence tiers at a glance
Good evidence: medical Rx, UAE, MRgFUS for symptom relief
Needs more research: fertility safety of UAE/MRgFUS; SPRM long-term effects
Abbreviation Key
- UAE — uterine artery embolisation
- STEPW — size, topography, extension, penetration, lateral wall (classification)
- MRgFUS — magnetic resonance imaging-guided focused ultrasound
- NICE — National Institute for Health and Care Excellence
- GnRH — gonadotrophin-releasing hormone
- FDA — Food and Drug Administration
- SPRM — selective progesterone-receptor modulator
- OR — odds ratio
- UA — ulipristal acetate
- CI — confidence interval
- LNG-IUS — levonorgestrel intrauterine system
- PICO — participants, intervention, comparison, outcome
- ESGE — European Society of Gynaecological Endoscopy
- CASP — Critical Appraisal Skills Programme
- FIGO — International Federation of Gynaecology and Obstetrics
Source: Younas K, Hadoura E, Majoko F, Bunkheila A. A review of evidence-based management of uterine fibroids. The Obstetrician & Gynaecologist 2016;18:33–42. doi:10.1111/tog.12223
MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).